Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet

Process Biochemistry

Volumn 45, Issue 8, 2010, Pages 1406-1414

  Bhuvaneswari, Saravanan ^a   Arunkumar, Elumalai ^a   Viswanathan, Periyasamy ^a   Anuradha, Carani Venkatraman ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Astaxanthin; Insulin resistance; Nitro oxidative stress; Obesity; Unbalanced diet

Indexed keywords

ANTIOXIDANT STATUS; ANTIOXIDANT SYSTEMS; ASTAXANTHIN; BENEFICIAL EFFECTS; BODY WEIGHT; ELEVATED PLASMA; FATTY LIVER DISEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DEPOSITION; LIVER INJURIES; MALE MOUSE; MYELOPEROXIDASE; OBESE MICE; OLIVE OIL; OXIDATIVE DAMAGE; TRANSFORMING GROWTH FACTORS; WEIGHT GAIN;

ANTHROPOMETRY; ECOLOGY; INSULIN; LIVER; MAMMALS; OXIDATIVE STRESS; VEGETABLE OILS;

NUTRITION;

MUS;

EID: 77954088486     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2010.05.016     Document Type: Article

References (54)

1. Richard D. Energy expenditure: a critical determinant of energy balance with key hypothalamic controls. Minerva Endocrinol 2007, 32:173-183.
2. Tessari P., Coracina A., Cosma A., Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2009, 19:291-302.
3. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., Mc-Cullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
4. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
5. Cheng K.S., Tang H.L., Chou F.T., Chou J.W., Hsu C.H., Yu C.J., et al. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma. Hepatogastroenterology 2009, 56:1105-1110.
6. Breitkopf K., Haas S., Wiercinska E., Singer M.V., Dooley S. Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res 2005, 29:121S-131S.
7. Aragno M., Tomasinelli C.E., Vercellinatto I., Catalano M.G., Collino M., Fantozzi R., et al. SREBP-1c in NAFDL induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med 2009, 47:1067-1074.
8. Messier C., Whately K., Liang J., Du L., Pussiant D. The effects of high-fat, high fructose and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behav Brain Res 2007, 178:139-145.
9. Wei Y., Wang D., Topczewski F., Pagliassotti M.J. Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. J Nutr Biochem 2007, 18:1-9.
10. Lorenz R.T., Cysewski G.R. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol 2000, 18:160-167.
11. Ip P.-F., Chen F. Employment of reactive oxygen species to enhance astaxanthin formation in Chlorella zofingiensis in heterotrophic culture. Proc Biochem 2005, 40:3491-3496.
12. Qin S., Liu G.-X., Hu Z.-Y. The accumulation and metabolism of astaxanthin in Scenedesmus obliquus (Chlorophyceae). Proc. Biochem. 2008, 43:795-802.
13. Malmsten C. Dietary supplementation with astaxanthin-rich algal meal improves muscle endurance-a double blind study on male students 1998, Karolinska Institute, Gustavsberg, Sweden.
14. Guerin M., Huntley M.E., Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003, 21:210-216.
15. Pashkow F.J., Watumull D.G., Campbell C.L. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 2008, 101:58D-68D.
16. Hussein G., Nakamura M., Zhao Q., Iguchi T., Goto H., Sankawa U., et al. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol Pharm Bull 2005, 28:47-52.
17. Ikeuchi M., Koyama T., Takahashi J., Yazawa K. Effects of astaxanthin supplementation on exercise-induced fatigue in mice. Biol Pharm Bull 2006, 29:2106-2110.
18. Zhang X., Pan L., Wei X., Gao H., Liu J. Impact of astaxanthin-enriched algal powder of Haematococcus pluvialis on memory improvement in BALB/c mice. Environ Geochem Health 2007, 29:483-489.
19. Ikeuchi M., Koyama T., Takahashi J., Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 2007, 71:893-899.
20. Uchiyama K., Naito Y., Hasegawa G., Nakamura N., Takahashi J., Yoshikaw T. Astaxanthin protects β-cells against glucose toxicity in diabetic db/db mice. Redox Report 2002, 7(5):290-293.
21. Naito Y., Uchiyama K., Aoi W., Hasegawa G., Nakamura N., Yoshida N., et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. BioFactors 2004, 20:49-59.
22. Mathews D.R., Hosker J.P., Rudenkl A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
24. Wu D.F., Clejan L., Potter B., Cederbaum A.I. Rapid decrease of cytochrome P-450IIE1 in primary hepatocyte culture and its maintenance by added 4-methylpyrazole. Hepatology 1990, 12:1379-1389.
25. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209.
26. Nieuhas W.G., Samuelson S. Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968, 6:126-130.
27. Jiang Z.Y., Hunt J.V., Wolf S.P. Detection of lipid hydroperoxides using the FOX method. Anal Biochem 1992, 202:384-389.
28. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
29. Rock E., Astier C., Lab C., Malpuech C. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes Res 1995, 8:237-242.
30. Cook J.A., Kim S.Y., Teague D. Convenient colorimetric and fluorometric assays for S-Nitrosothiols. Anal Biochem 1996, 238:150-158.
31. AnithaNandhini A.T., Balakrishnan S.D., Anuradha C.V. Taurine modulates antioxidant potential and controls lipid peroxidation in the aorta of high fructose-fed rats. J Biochem Mol Biol Biophys 2002, 6:129-133.
32. Folch J., Lees M., SloaneStanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
33. Lowry O.H., Rosebrough N., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
34. Unger R.H. Lipotoxic diseases. Annu Rev Med 2002, 53:319-336.
35. Beltroy E.P., Liu B., Dietschy J.M., Turley S.D. Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease. J Lipid Res 2007, 48:869-881.
36. Aoi W., Naito Y., Takanami Y., Ishii T., Kawai Y., Akagiri S., et al. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem Biophys Res Commun 2008, 366:892-897.
37. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 1987, 245:243-250.
38. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways. A unifying hypothesis of type 2 diabetes. Endocr Rev 2009, 23:599-622.
39. Grune T., Blasig I.E., Sitte N., Roloff B., Haseloff R., Davies K.J. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteosome. J Biol Chem 1998, 273:10857-10862.
40. Piconi L., Quagliaro L., Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003, 41:1144-1149.
41. Datta K., Sinha S., Chattopadhyay P. Reactive oxygen species in health and diseases. Natl Med J India 2000, 13:304-310.
42. Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K., Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. J Biol Chem 1987, 262:16969-16972.
43. Miki W. Biological functions and activities of animal carotenoids. J Agric Food Chem 1991, 63:141-146.
44. Kobayashi M. In vivo antioxidant role of astaxanthin under oxidative stress in the green algae Haematococcus pluvialis. Appl Microbiol Biotechnol 2000, 54:550-555.
45. Goto S., Kogure K., Abe K., Kimata Y., Kimtahama K., Yamashita E., et al. Efficient radical trapping at the surface and iniside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochem Biophys Acta 2001, 1512:251-258.
46. Manabe E., Handa O., Naito Y., Mizushima K., Akagiri S., Adachi S., et al. Astaxanthin protects mesengial cells from hyperglycemia-induced oxidative signaling. J Cell Biochem 2008, 103:1925-1937.
47. Araki E., Murakami T., Shirotoni T. A cluster of four SP1 binding sites required for efficient expression of the human insulin receptor gene. J Biol Chem 1991, 6:3944-3948.
48. Weltman M.D., Farrell G.C., Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996, 111:1645-1653.
49. Schattenberg J.M., Wang Y., Singh R., Rigoli R.M., Czaja M.J. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem 2005, 280:9887-9894.
50. Chen S., Jim B., Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis mand fibrosis build-up. Semin Nephrol 2003, 23:532-543.
51. Kurashige M., Okimasu E., Inoue M., Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 1990, 22:27-38.
52. Rufer C.E., Moeseneder J., Briviba K., Rechkemmer G., Bub A. bioavailability of astaxanthin stereoisomers from wild (Oncorhynchus spp.) and aquacultured (Salmo salar) salmon in healthy men: a randomized, double blind study. Br J Nutr 2008, 99(5):1048-1054.
53. Dirlewanger W., Schneiter P., JequierbE, Tappy L. Effects of fructose on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab 2000, 279:907-911.
54. Fassett R.G., Coombes J.S. Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiol 2009, 5:333-342.